Curapath and Cristal Therapeutics Sign Co-Exclusive License of CliCr® Bioconjugation Platform
Curapath and Cristal Therapeutics partner to bring CliCr® bioconjugation to targeted nanoparticle delivery, advancing next-generation therapies. PATERNA, VALENCIA, SPAIN, November 26, 2025 /EINPresswire.com/ -- 𝗖𝘂𝗿𝗮𝗽𝗮𝘁𝗵,, a leading innovator in the …